A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes. - Curtin, Francois; Champion, Bernard; Davoren, Peter; Duke, Sally; Ekinci, Elif I.; Gilfillan, Chris; Morbey, Claire; Nathow, Thomas; O'Moore‐Sullivan, Trisha; O'Neal, David; Roberts, Adam; Stranks, Stephen; et al. (Diabetes, Obesity & Metabolism, 2020)